This Chart Shows Why AstraZeneca PLC's Rejection Won't Send Pfizer Inc. Hunting For Another Deal

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In a Memorial Day whimper, Pfizer PFE +0.3% announced yesterday that it will withdraw its bid for London’s AstraZeneca , meaning that it will have to take a breather of at least three months and maybe six before issuing another bid. Most likely, this sets up a long pattern where Pfizer executives sit in wait, hoping that Astra will stumble and its investors will push it into a Pfizer merger.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news